Research Progress of PROTAC-Degraded CDKs in the Treatment of Breast Cancer. [PDF]
Zhao K +7 more
europepmc +1 more source
FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA. [PDF]
He Q +14 more
europepmc +1 more source
Novel 2,6,9-Trisubstituted Purines as CDK2 Inhibitors for Treating Cancers. [PDF]
Rong J, Liang SH.
europepmc +1 more source
Effect of perinatal sterile gloves on neonatal mortality: a post hoc analysis of a randomised clinical trial in Zambia. [PDF]
Cui M +8 more
europepmc +1 more source
Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer. [PDF]
Rahman R, Selth LA.
europepmc +1 more source
Cdk activation by phosphorylation: linking growth signals to cell cycle control. [PDF]
Blank HM, No EG, Polymenis M.
europepmc +1 more source
Phosphatases: An undervalued class of antitumor drug targets. [PDF]
Wang M, Zhan P, Song Y.
europepmc +1 more source
<i>Silybum marianum</i>-Derived Compounds in Prostate Cancer: Mechanisms of Action and Translational Potential. [PDF]
Randisi F +6 more
europepmc +1 more source
Editorial: Molecular modeling in drug repurposing. [PDF]
Filipe HAL +3 more
europepmc +1 more source
New predicted dual CDK-2/CDK-1 inhibitors from Aspergillus unguis isolate SP51-EGY with relative selectivity for colorectal cancer cells: a computational and experimental approach. [PDF]
El-Rashedy AA +4 more
europepmc +1 more source

